Federal Court Temporarily Halts Removal of Teva’s Asthma Inhaler Patents Amid Appeal Process

The Federal Circuit has decided to temporarily halt the removal of Teva Pharmaceuticals’ asthma inhaler device patents from an important government database while the Israeli drugmaker appeals a prior decision. This move comes as Teva challenges an order that had favored Amneal Pharmaceuticals in an infringement lawsuit. The ruling allows Teva to maintain its patents’ protection until the appeal process is completed. For further details, you can read more about the development here.